HER2-directed therapy: current treatment options for HER2-positive breast cancerShahid Ahmed, Jim Xiang, Amer Sami|Breast Cancer|2015Cited by 183
Extrapulmonary small cell cancerKamal Haider, Shahid Ahmed, Rabia Shahid et al.|Cancer|2006Cited by 123
Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast CancerSamitha Andrahennadi, Shahid Ahmed, Amer Sami et al.|Current Oncology|2021Cited by 60
Early Discontinuation but Not the Timing of Adjuvant Therapy Affects Survival of Patients With High-Risk Colorectal Cancer: A Population-Based StudyShahid Ahmed, Kamal Haider, Imran Ahmad et al.|Diseases of the Colon & Rectum|2010Cited by 53
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude miceLu Wang, Jim Xiang, Yufeng Xie et al.|Breast Cancer Research and Treatment|2013Cited by 48